Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs Ibuprofen + HBB for Pain in Outpatient Hysteroscopy
NCT06398054Phase 4Not yet recruiting
- Sponsor
- ASST Fatebenefratelli Sacco
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of hyoscine butylbromide in procedural pain (2 arms), sponsored by ASST Fatebenefratelli Sacco. Primary endpoint: Visual Analog Pain Score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06398054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06398054.